Oil

India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine

Credit: REUTERS/Dado Ruvic

India's Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID-19 vaccine using the drug substance made by Russia's Generium.

BENGALURU, Aug 5 (Reuters) - India's Panacea Biotec Ltd PNCA.NS said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID-19 vaccine using the drug substance made by Russia's Generium.

Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories REDY.NS for distribution in India. (https://bit.ly/3joeloz)

(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Shailesh Kuber)

((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Commodities Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More